2 years ago
ARQT
AnalystsUy EarUy Ear's Stock Forecasts
AnalystsUy Ear
Analyst Ranking
Top 23%
#1150 out of 5192 analysts
Average Return
+8.58%
Win Rate
45%23 out of 51
Risk vs Reward
Poor
Good
Uy Ear's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | +306.12% | $3.43 | $13.93 | 2024-01-02 - 2024-12-31 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +272.38% | $3.91 | $14.56 | 2024-01-03 - 2025-01-02 | Strong Buy |
Mbx Biosciences IncMBX | +217.99% | $11.95 | $38.00 | 2025-08-05 - 2026-02-12 | Buy |
Cabaletta Bio IncCABA | +131.36% | $8.10 | $18.74 | 2023-03-17 - 2024-03-15 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +102.04% | $13.22 | $26.71 | 2025-02-26 - 2026-02-12 | Buy |
Uy Ear Analyst Color
Get additional color on Uy Ear's coverage of popular stocks
Uy Ear's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 10 | Hold | $175.00 | +42.16% | Maintains | 2 months ago |
Uniqure NvQURE | 6 | Buy | $33.00 | +47.52% | Maintains | 2 months ago |
Evolus IncEOLS | 4 | Buy | $19.00 | +343.93% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 15 | Hold | $29.00 | +34.20% | Maintains | 2 months ago |
Arcutis Biotherapeutics IncARQT | 14 | Buy | $37.00 | +38.52% | Maintains | 3 months ago |
Relmada Therapeutics IncRLMD | 2 | Buy | $10.00 | +156.41% | Upgrades | 3 months ago |
Sarepta Therapeutics IncSRPT | 8 | Buy | $26.00 | +49.43% | Upgrades | 3 months ago |
Alkermes PLCALKS | 6 | Buy | $45.00 | +35.18% | Maintains | 4 months ago |
Mbx Biosciences IncMBX | 2 | Buy | $56.00 | +47.37% | Maintains | 5 months ago |
Tectonic Therapeutic IncTECX | 6 | Buy | $85.00 | +274.28% | Maintains | 9 months ago |
Sage Therapeutics IncSAGE | 2 | Hold | $16.00 | N/A | Maintains | 2 years ago |
Cartesian Therapeutics IncRNAC | 3 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Johnson & JohnsonJNJ | 1 | Strong Buy | $40.00 | N/A | Maintains | 3 years ago |
Satsuma Pharmaceuticals IncSTSA | 1 | Hold | $2.00 | N/A | Reiterates | 3 years ago |
Cabaletta Bio IncCABA | 1 | Strong Buy | $10.00 | N/A | Reiterates | 3 years ago |
Ocugen IncOCGN | 2 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.